Select Topic:
Browse by Series:

AUA Castration-Resistant Prostate Cancer Guidelines

Panelists: Philippa J. Cheetham, MD, Stonybrook University;Raoul S. Concepcion, MD, Urology Associates, PC; Kenneth M. Kernen, MD, Michigan Urology;
Published: Wednesday, Jun 18, 2014

For High-Definition, Click
The AUA announced their guidelines for the treatment of men with castration-resistant prostate cancer (CRPC) in May of 2013 at their Annual Meeting. This guideline outlines the optimal management of six index patients across a variety of disease settings ranging from M0 CRPC to progressive disease, notes Neal D. Shore, MD (See slide in video for further description).

The therapeutic recommendations within the guideline were based on the level of published evidence available, with level A representing the strongest level of support. Based on the accumulation of additional data, AUA has recently added treatment with radium-223 to the guideline for men with bone metastatic CRPC, notes Shore. 

Slider Left
Slider Right
For High-Definition, Click
The AUA announced their guidelines for the treatment of men with castration-resistant prostate cancer (CRPC) in May of 2013 at their Annual Meeting. This guideline outlines the optimal management of six index patients across a variety of disease settings ranging from M0 CRPC to progressive disease, notes Neal D. Shore, MD (See slide in video for further description).

The therapeutic recommendations within the guideline were based on the level of published evidence available, with level A representing the strongest level of support. Based on the accumulation of additional data, AUA has recently added treatment with radium-223 to the guideline for men with bone metastatic CRPC, notes Shore. 
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x